Indication

Tertiary bejel

Tertiary bejel represents the late, destructive stage of endemic nonvenereal syphilis caused by the spirochete bacterium *Treponema pallidum* subspecies *endemicum*. Read more about Tertiary bejel

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Tertiary bejel therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Tertiary bejel preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Tertiary bejel.

Tertiary bejel represents the late, destructive stage of endemic nonvenereal syphilis caused by the spirochete bacterium *Treponema pallidum* subspecies *endemicum*.

Primarily affecting populations in arid, resource-limited regions—frequently arising years after initial childhood exposure—this phase predominantly impacts the skeletal system, mucocutaneous tissues, and upper respiratory tract.

Pathophysiologically, it is characterized by chronic granulomatous inflammation leading to destructive gummatous lesions, chronic osteoperiostitis of long bones, and extensive ulceration with necrosis of the palate and nasal cartilage, causing profound facial disfigurement.

Unlike tertiary venereal syphilis, cardiovascular and central nervous system involvement is classically absent.

Personalize your experience

Follow Tertiary bejel and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it